PCSK1 Variants and Human Obesity

Progress in Molecular Biology and Translational Science

Volumn 140, Issue , 2016, Pages 47-74

  Ramos Molina, B ^a   Martin, M G ^b   Lindberg, I ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

feeding; genome wide association studies; glucose metabolism; obesity; PC1 3; PCSK1; peptide hormone; posttranslational processing; prohormone convertase 1 3; secretory pathway

Indexed keywords

INSULIN; MELANOCORTIN; NEUROPEPTIDE; PEPTIDE HORMONE; PROHORMONE CONVERTASE 1; PROINSULIN; PROPROTEIN CONVERTASE 1; UNCLASSIFIED DRUG; PCSK1 PROTEIN, HUMAN;

ENDOCRINE DISEASE; ENERGY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEEDING BEHAVIOR; GASTROINTESTINAL TRACT; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HYPOTHALAMUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PCSK1 GENE; GENETICS; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

HUMANS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPROTEIN CONVERTASE 1;

EID: 84955586312     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/bs.pmbts.2015.12.001     Document Type: Chapter

References (137)

1. Seidah, N.G., The proprotein convertases, 20 years later. Methods Mol Biol 768 (2011), 23–57.
2. Hoshino, A., Lindberg, I., Fricker, L.D., Devi, L., (eds.) PeptideBiosynthesis:ProhormoneConvertases1/3and2., 2012, Morgan & Claypool Life Sciences Publishers, Princeton, NJ.
3. Thomas, G., Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3:10 (2002), 753–766.
4. Zhu, X., Zhou, A., Dey, A., et al. Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA 99:16 (2002), 10293–10298.
5. Furuta, M., Yano, H., Zhou, A., et al. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci USA 94 (1997), 6646–6651.
6. Jackson, R.S., Creemers, J.W., Ohagi, S., et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 16 (1997), 303–306.
7. Farooqi, S., O'Rahilly, S., Genetics of obesity in humans. Endocr Rev 27:7 (2006), 710–718.
8. Martin, M.G., Lindberg, I., Solorzano-Vargas, R.S., et al. Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort. Gastroenterology 145:1 (2013), 138–148.
9. Farooqi, I.S., Volders, K., Stanhope, R., et al. Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. J Clin Endocrinol Metab 92:9 (2007), 3369–3373.
10. Stijnen, P., Tuand, K., Varga, T.V., Franks, P.W., Aertgeerts, B., Creemers, J.W., The association of common variants in PCSK1 with obesity: a HuGE review and meta-analysis. Am J Epidemiol 180:11 (2014), 1051–1065.
11. Nead, K.T., Li, A., Wehner, M.R., et al. Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals. Hum Mol Genet 24:12 (2015), 3582–3594.
12. Seidah, N.G., Marcinkiewicz, M., Benjannet, S., et al. Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, furin, and Kex2: distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2. Mol Endocrinol 5:1 (1991), 111–122.
13. Smeekens, S.P., Avruch, A.S., LaMendola, J., Chan, S.J., Steiner, D.F., Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans. Proc Natl Acad Sci USA 88 (1991), 340–344.
14. Seidah, N.G., Mattei, M.G., Gaspar, L., Benjannet, S., Mbikay, M., Chretien, M., Chromosomal assignments of the genes for neuroendocrine convertase PC1 (NEC1) to human 5q15-21, neuroendocrine convertase PC2 (NEC2) to human 20p11.1-11.2, and furin (mouse 7[D1-E2] region). Genomics 11:1 (1991), 103–107.
15. Creemers, J.W., Vey, M., Schafer, W., et al. Endoproteolytic cleavage of its propeptide is a prerequisite for efficient transport of furin out of the endoplasmic reticulum. J Biol Chem 270:6 (1995), 2695–2702.
16. Zhou, A., Martin, S., Lipkind, G., LaMendola, J., Steiner, D.F., Regulatory role of the P domain of subtilisin-like prohormone convertases. J Biol Chem 273 (1998), 11107–11114.
17. Dikeakos, J.D., Di Lello, P., Lacombe, M.J., et al. Functional and structural characterization of a dense core secretory granule sorting domain from the PC1/3 protease. Proc Natl Acad Sci USA 106:18 (2009), 7408–7413.
18. Hoshino, A., Kowalska, D., Jean, F., Lazure, C., Lindberg, I., Modulation of PC1/3 activity by self-interaction and substrate binding. Endocrinology 152:4 (2011), 1402–1411.
19. Benjannet, S., Rondeau, N., Paquet, L., et al. Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2. Biochem J 294:Pt 3 (1993), 735–743.
20. Lindberg, I., Evidence for cleavage of the PC1/PC3 pro-segment in the endoplasmic reticulum. Mol Cell Neurosci 5:3 (1994), 263–268.
21. Anderson, E.D., VanSlyke, J.K., Thulin, C.D., Jean, F., Thomas, G., Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage. EMBO J 16:7 (1997), 1508–1518.
22. Feliciangeli, S.F., Thomas, L., Scott, G.K., et al. Identification of a pH sensor in the furin propeptide that regulates enzyme activation. J Biol Chem 281:23 (2006), 16108–16116.
23. Dillon, S.L., Williamson, D.M., Elferich, J., et al. Propeptides are sufficient to regulate organelle-specific pH-dependent activation of furin and proprotein convertase 1/3. J Mol Biol 423:1 (2012), 47–62.
24. Paquet, L., Zhou, A., Chang, E.Y., Mains, R.E., Peptide biosynthetic processing: distinguishing prohormone convertases PC1 and PC2. Mol Cell Endocrinol 120:2 (1996), 161–168.
25. Schnabel, E., Mains, R.E., Farquahar, M.G., Proteolytic processing of proACTH-endorphin begins in the Golgi complex of pituitary corticotropes and AtT-20 cells. Mol Endocrinol 3:8 (1989), 1223–1234.
26. Zandberg, W.F., Benjannet, S., Hamelin, J., Pinto, B.M., Seidah, N.G., N-Glycosylation controls trafficking, zymogen activation, and substrate processing of proprotein convertases PC1/3 and SKI-1. Glycobiology 21:10 (2011), 1290–1300.
27. Zhou, Y., Lindberg, I., Enzymatic properties of carboxyl-terminally truncated prohormone convertase 1 (PC1/SPC3) and evidence for autocatalytic conversion. J Biol Chem 269:28 (1994), 18408–18413.
28. Boudreault, A., Gauthier, D., Rondeau, N., et al. Molecular characterization, enzymatic analysis, and purification of murine proprotein convertase-1/3 (PC1/PC3) secreted from recombinant baculovirus-infected insect cells. Protein Expr Purif 14:3 (1998), 353–366.
29. Lloyd, D.J., Bohan, S., Gekakis, N., Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. Hum Mol Genet 15:11 (2006), 1884–1893.
30. Dong, W., Seidel, B., Marcinkiewicz, M., Chretien, M., Seidah, N.G., Day, R., Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids. J Neurosci 17:2 (1997), 563–575.
31. Damholt, A.B., Buchan, A.M., Holst, J.J., Kofod, H., Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2. Endocrinology 140:10 (1999), 4800–4808.
32. Itoh, Y., Tanaka, S., Takekoshi, S., Itoh, J., Osamura, R.Y., Prohormone convertases (PC1/3 and PC2) in rat and human pancreas and islet cell tumors: subcellular immunohistochemical analysis. Pathol Int 46:10 (1996), 726–737.
33. Kurabuchi, S., Tanaka, S., Immunocytochemical localization of prohormone convertases PC1 and PC2 in the mouse thyroid gland and respiratory tract. J Histochem Cytochem 50:7 (2002), 903–909.
34. Takumi, I., Steiner, D.F., Sanno, N., Teramoto, A., Osamura, R.Y., Localization of prohormone convertases 1/3 and 2 in the human pituitary gland and pituitary adenomas: analysis by immunohistochemistry, immunoelectron microscopy, and laser scanning microscopy. Mod Pathol 11:3 (1998), 232–238.
35. Tanaka, S., Kurabuchi, S., Mochida, H., et al. Immunocytochemical localization of prohormone convertases PC1/PC3 and PC2 in rat pancreatic islets. Arch Histol Cytol 59:3 (1996), 261–271.
36. Zhou, A., Bloomquist, B.T., Mains, R.E., The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem 268:3 (1993), 1763–1769.
37. Benjannet, S., Rondeau, N., Day, R., Chretien, M., Seidah, N.G., PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA 88:9 (1991), 3564–3568.
38. Thomas, L., Leduc, R., Thorne, B.A., Smeekens, S.P., Steiner, D., Thomas, G., Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes. Proc Natl Acad Sci USA 88 (1991), 5297–5301.
39. Wardman, J.H., Zhang, X., Gagnon, S., et al. Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics. J Neurochem 114:1 (2010), 215–225.
40. Cowley, M.A., Smart, J.L., Rubinstein, M., et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:6836 (2001), 480–484.
41. Belgardt, B.F., Okamura, T., Bruning, J.C., Hormone and glucose signalling in POMC and AgRP neurons. J Physiol 587:Pt 22 (2009), 5305–5314.
42. Xu, Y., Elmquist, J.K., Fukuda, M., Central nervous control of energy and glucose balance: focus on the central melanocortin system. Ann NY Acad Sci 1243 (2011), 1–14.
43. Ollmann, M.M., Wilson, B.D., Yang, Y.K., et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:5335 (1997), 135–138.
44. D'Agostino, G., Diano, S., Alpha-melanocyte stimulating hormone: production and degradation. J Mol Med 88:12 (2010), 1195–1201.
45. Pan, H., Nanno, D., Che, F.Y., et al. Neuropeptide processing profile in mice lacking prohormone convertase-1. Biochemistry 44:12 (2005), 4939–4948.
46. Jackson, R.S., Creemers, J.W., Farooqi, I.S., et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 112:10 (2003), 1550–1560.
47. Dey, A., Xhu, X., Carroll, R., Turck, C.W., Stein, J., Steiner, D.F., Biological processing of the cocaine and amphetamine-regulated transcript precursors by prohormone convertases PC2 and PC1/3. J Biol Chem 278:17 (2003), 15007–15014.
48. Creemers, J.W., Pritchard, L.E., Gyte, A., et al. Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3. Endocrinology 147:4 (2006), 1621–1631.
49. Kalra, S.P., Dube, M.G., Pu, S., Xu, B., Horvath, T.L., Kalra, P.S., Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20:1 (1999), 68–100.
50. Paquet, L., Massie, B., Mains, R.E., Proneuropeptide Y processing in large dense-core vesicles: manipulation of prohormone convertase expression in sympathetic neurons using adenoviruses. J Neurosci 16:3 (1996), 964–973.
51. Nilaweera, K.N., Barrett, P., Mercer, J.G., Morgan, P.J., Precursor-protein convertase 1 gene expression in the mouse hypothalamus: differential regulation by ob gene mutation, energy deficit and administration of leptin, and coexpression with prepro-orexin. Neuroscience 119:3 (2003), 713–720.
52. Zhu, X., Orci, L., Carroll, R., Norrbom, C., Ravazzola, M., Steiner, D.F., Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proc Natl Acad Sci USA 99:16 (2002), 10299–10304.
53. Smeekens, S., Montag, A.G., Thomas, G., et al. Proinsulin processing by the subtilisin-related proprotein convertases furin PC2, and PC3. Proc Natl Acad Sci USA 89 (1992), 8822–8826.
54. Furuta, M., Carroll, R., Martin, S., et al. Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2. J Biol Chem 273 (1998), 1–7.
55. Yourshaw, M., Solorzano-Vargas, R.S., Pickett, L.A., et al. Exome sequencing finds a novel PCSK1 mutation in a child with generalized malabsorptive diarrhea and diabetes insipidus. J Pediatr Gastroenterol Nutr 57:6 (2013), 759–767.
56. Bandsma, R.H., Sokollik, C., Chami, R., et al. From diarrhea to obesity in prohormone convertase 1/3 deficiency: age-dependent clinical pathologic, and enteroendocrine characteristics. J Clin Gastroenterol 47:10 (2013), 834–843.
57. Frank, G.R., Fox, J., Candela, N., et al. Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency. Mol Genet Metab 110:1–2 (2013), 191–194.
58. O'Rahilly, S., Gray, H., Humphreys, P.J., et al. Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adenal function. New England J Med 333 (1995), 1386–1390.
59. Rouille, Y., Westermark, G., M., S.K., Steiner, D.F., Proglucagon is processed to glucagon by prohormone convertase PC2 in alphaTC1-6 cells. Proc Natl Acad Sci USA 91 (1994), 3242–3246.
60. Furuta, M., Zhou, A., Webb, G., Ravazzola, M., Orci, L., Steiner, D.F., Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J Biol Chem 276 (2001), 27197–27202.
61. Rouille, Y., Bianchi, M., Irminger, J.C., Halban, P.A., Role of prohormone convertase PC2 in the processing of proglucagon to glucagon. FEBS Lett 413 (1997), 119–123.
62. Rouille, Y., Martin, S., Steiner, D.F., Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide. J Biol Chem 270:44 (1995), 26488–26496.
63. Dhanvantari, S., Seidah, N.G., Brubaker, P.L., Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol Endocrinol 10 (1996), 342–355.
64. Rouille, Y., Kantengwa, S., Irminger, J.C., Halban, P.A., Role of the prohormone convertases in the processing of proglucagon to glucagon-like peptides. J Biol Chem 72 (1997), 32810–32816.
65. Drucker, D.J., Yusta, B., Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Ann Rev Physiol 76 (2014), 561–583.
66. Dailey, M.J., Moran, T.H., Glucagon-like peptide 1 and appetite. Trends Endocrinol Metab 24:2 (2013), 85–91.
67. Ugleholdt, R., Poulsen, M.L., Holst, P.J., et al. Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor. J Biol Chem 281:16 (2006), 11050–11057.
68. Usdin, T.B., Mezey, E., Button, D.C., Brownstein, M.J., Bonner, T.I., Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133:6 (1993), 2861–2870.
69. Paschetta, E., Hvalryg, M., Musso, G., Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders. Obes Rev 12:10 (2011), 813–828.
70. Zhu, X., Cao, Y., Voogd, K., Steiner, D.F., On the processing of proghrelin to ghrelin. J Biol Chem 281:50 (2006), 38867–38870.
71. Ozawa, A., Cai, Y., Lindberg, I., Production of bioactive peptides in an in vitro system. Anal Biochem 366:2 (2007), 182–189.
72. Shintani, M., Ogawa, Y., Ebihara, K., et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50 (2001), 227–232.
73. Gagnon, J., Baggio, L.L., Drucker, D.J., Brubaker, P.L., Ghrelin is a novel regulator of GLP-1 secretion. Diabetes 64 (2015), 1513–1521.
74. Wang, W., Birch, N.P., Beinfeld, M.C., Prohormone convertase 1 (PC1) when expressed with pro cholecystokinin (pro CCK) in L cells performs three endoproteolytic cleavages which are observed in rat brain and in CCK-expressing endocrine cells in culture, including the production of glycine and arginine extended CCK8. Biochem Biophys Res Commun 248:3 (1998), 538–541.
75. Rehfeld, J.F., Zhu, X., Norrbom, C., et al. Prohormone convertases 1/3 and 2 together orchestrate the site-specific cleavages of progastrin to release gastrin-34 and gastrin-17. Biochem J 415:1 (2008), 35–43.
76. Svendsen, B., Pedersen, J., Albrechtsen, N.J.W., et al. An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine. Endocrinology 156 (2015), 847–857.
77. Rehfeld, J.F., Gastrointestinal hormones and their targets. Adv Exp Med Biol 817 (2014), 157–175.
78. Mbikay, M., Croissandeau, G., Sirois, F., et al. A targeted deletion/insertion in the mouse Pcsk1 locus is associated with homozygous embryo preimplantation lethality, mutant allele preferential transmission and heterozygous female susceptibility to dietary fat. Dev Biol 306:2 (2007), 584–598.
79. Prabhu, Y., Blanco, E.H., Liu, M., et al. Defective transport of the obesity mutant PC1/3 N222D contributes to loss of function. Endocrinology 155:7 (2014), 2391–2401.
80. Blanco, E.H., Ramos-Molina, B., Lindberg, I., Revisiting PC1/3 mutants: dominant-negative effect of endoplasmic reticulum-retained mutants. Endocrinology 156:10 (2015), 3625–3637 en20151068.
81. Creemers, J.W., Choquet, H., Stijnen, P., et al. Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes 61:2 (2012), 383–390.
82. Choquet, H., Kasberger, J., Hamidovic, A., Jorgenson, E., Contribution of common PCSK1 genetic variants to obesity in 8,359 subjects from multi-ethnic American population. PLoS One, 8(2), 2013, e57857.
83. Villalobos-Comparan, M., Villamil-Ramirez, H., Villarreal-Molina, T., et al. PCSK1 rs6232 is associated with childhood and adult class III obesity in the Mexican population. PLoS One, 7(6), 2012, e39037.
84. Turpeinen, H., Ortutay, Z., Pesu, M., Genetics of the first seven proprotein convertase enzymes in health and disease. Curr Genomics 14:7 (2013), 453–467.
85. Benzinou, M., Creemers, J.W., Choquet, H., et al. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet 40:8 (2008), 943–945.
86. Heni, M., Haupt, A., Schafer, S.A., et al. Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion. BMC Med Genet, 11, 2010, 86.
87. Strawbridge, R.J., Dupuis, J., Prokopenko, I., et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60:10 (2011), 2624–2634.
88. Kilpelainen, T.O., Bingham, S.A., Khaw, K.T., Wareham, N.J., Loos, R.J., Association of variants in the PCSK1 gene with obesity in the EPIC-Norfolk study. Hum Mol Genet 18:18 (2009), 3496–3501.
89. Qi, Q., Li, H., Loos, R.J., et al. Association of PCSK1 rs6234 with obesity and related traits in a Chinese Han population. PLoS One, 5(5), 2010, e10590.
90. Gjesing, A.P., Vestmar, M.A., Jorgensen, T., et al. The effect of PCSK1 variants on waist, waist-hip ratio and glucose metabolism is modified by sex and glucose tolerance status. PLoS One, 6(9), 2011, e23907.
91. Mbikay, M., Sirois, F., Nkongolo, K.K., Basak, A., Chretien, M., Effects of rs6234/rs6235 and rs6232/rs6234/rs6235 PCSK1 single-nucleotide polymorphism clusters on proprotein convertase 1/3 biosynthesis and activity. Mol Genet Metab 104:4 (2011), 682–687.
92. Blanco, E.H., Peinado, J.R., Martin, M.G., Lindberg, I., Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph. Endocrinology 155:9 (2014), 3434–3447.
93. Li, L., Gao, K., Zhao, J., et al. Glucagon gene polymorphism modifies the effects of smoking and physical activity on risk of type 2 diabetes mellitus in Han Chinese. Gene 534 (2014), 352–355.
94. Canani, R.B., Castaldo, G., Bacchetta, R., Martín, M.G., Goulet, O., Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies. Nat Rev Gastroenterol Hepatol 12 (2015), 293–302.
95. Wang, J., Cortina, G., Wu, S.V., et al. Mutant neurogenin-3 in congenital malabsorptive diarrhea. New England J Med 355 (2006), 270–280.
96. Walley, A.J., Asher, J.E., Froguel, P., The genetic contribution to non-syndromic human obesity. Nat Rev Genet 10 (2009), 431–442.
97. Farooqi, I.S., Keogh, J.M., Yeo, G.S.H., Lank, E.J., Cheetham, T., O'Rahilly, S., Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. New England J Med 348 (2003), 1085–1095.
98. Gradwohl, G., Dierich, A., LeMeur, M., Guillemot, F., Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 97 (2000), 1607–1611.
99. Jeppesen, P.B., Gut hormones in the treatment of short-bowel syndrome and intestinal failure. Curr Opin Endocrinol Diab Obes 22 (2015), 14–20.
100. Syed, Y.Y., McCormack, P.L., Exenatide extended-release: an updated review of its use in type 2 diabetes mellitus. Drugs 75 (2015), 1141–1152.
101. Martinelli, C.E., Keogh, J.M., Greenfield, J.R., et al. Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metabol 96 (2011), E181–E188.
102. Clément, K., Vaisse, C., Lahlou, N., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392 (1998), 398–401.
103. Wilschanski, M., Abbasi, M., Blanco, E., et al. A novel familial mutation in the PCSK1 gene that alters the oxyanion hole residue of proprotein convertase 1/3 and impairs its enzymatic activity. PLoS One, 9(10), 2014, e108878.
104. Durand, C., Rappold, G.A., Height matters-from monogenic disorders to normal variation. Nat Rev Endocrinol 9 (2013), 171–177.
105. Lango Allen, H., Estrada, K., Lettre, G., et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467 (2010), 832–838.
106. Hotamisligil, G.S., Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:6 (2010), 900–917.
107. Ozcan, U., Cao, Q., Yilmaz, E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:5695 (2004), 457–461.
108. Philippe, J., Stijnen, P., Meyre, D., et al. A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity. Int J Obes 39:2 (2015), 295–302.
109. Rohden, F., Costa, C.S., Hammes, T.O., et al. Obesity associated with type 2 diabetes mellitus is linked to decreased PC1/3 mRNA expression in the Jejunum. Obes Surg 24 (2014), 2075–2081.
110. Ahlqvist, E., Turrini, F., Lang, S.T., et al. A common variant upstream of the PAX6 gene influences islet function in man. Diabetologia 55 (2012), 94–104.
111. Challis, B.G., Pritchard, L.E., Creemers, J.W., et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 11:17 (2002), 1997–2004.
112. Creemers, J.W., Lee, Y.S., Oliver, R.L., et al. Mutations in the amino-terminal region of proopiomelanocortin (POMC) in patients with early-onset obesity impair POMC sorting to the regulated secretory pathway. J Clin Endocrinol Metab 93:11 (2008), 4494–4499.
113. Farooqi, I.S., Drop, S., Clements, A., et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 55:9 (2006), 2549–2553.
114. Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., Gruters, A., Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:2 (1998), 155–157.
115. Yaswen, L., Diehl, N., Brennan, M., Hochgeschwender, U., Obesity in the mouse model of pro-opimelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:9 (1999), 1066–1070.
116. Alsters, S.I.M., Goldstone, A.P., Buxton, J.L., et al. Truncating homozygous mutation of carboxypeptidase E (CPE) in a morbidly obese female with type 2 diabetes mellitus intellectual disability and hypogonadotrophic hypogonadism. PloS One, 10, 2015, e0131417.
117. Naggert, J.K., Fricker, L.D., Varlamov, O., et al. Hyperproinsulinemia in obese fat/fat mice associated with a point mutation in the carboxypeptidase R gene and reduced enzyme activity. Nat Genet 1995 (1995), 135–142.
118. Srinivasan, S., Bunch, D.O., Feng, Y., et al. Deficits in reproduction and pro-gonadotropin-releasing hormone processing in male Cpefat mice. Endocrinology 145:4 (2004), 2023–2034.
119. Berman, Y., Mzhavia, N., Polonskaia, A., Devi, L.A., Impaired prohormone convertases in cpefat/cpefat mice. J Biol Chem 276 (2001), 1466–1473.
120. Fricker, L.D., McKinzie, A.A., Sun, J., et al. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci 20:2 (2000), 639–648.
121. Kudo, H., Liu, J., Jansen, E.J., et al. Identification of proSAAS homologs in lower vertebrates: conservation of hydrophobic helices and convertase-inhibiting sequences. Endocrinology 150:3 (2009), 1393–1399.
122. Chun, J.Y., Korner, J., Kreiner, T., Scheller, R.H., Axel, R., The function and differential sorting of a family of aplysia prohormone processing enzymes. Neuron 12:4 (1994), 831–844.
123. Feng, Y., Reznik, S.E., Fricker, L.D., Distribution of proSAAS-derived peptides in rat neuroendocrine tissues. Neuroscience 105:2 (2001), 469–478.
124. Feng, Y., Reznik, S.E., Fricker, L.D., ProSAAS and prohormone convertase 1 are broadly expressed during mouse development. Brain Res Gene Expr Patterns 1:2 (2002), 135–140.
125. Atkins, N. Jr., Mitchell, J.W., Romanova, E.V., et al. Circadian integration of glutamatergic signals by little SAAS in novel suprachiasmatic circuits. PLoS One, 5(9), 2010, e12612.
126. Mzhavia, N., Berman, Y., Che, F.Y., Fricker, L.D., Devi, L.A., ProSAAS processing in mouse brain and pituitary. J Biol Chem 276:9 (2001), 6207–6213.
127. Sayah, M., Fortenberry, Y., Cameron, A., Lindberg, I., Tissue distribution and processing of proSAAS by proprotein convertases. J Neurochem 76:6 (2001), 1833–1841.
128. Qian, Y., Devi, L.A., Mzhavia, N., Munzer, S., Seidah, N.G., Fricker, L.D., The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1. J Biol Chem 275:31 (2000), 23596–23601.
129. Cameron, A., Fortenberry, Y., Lindberg, I., The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1. FEBS Lett 473:2 (2000), 135–138.
130. Apletalina, E., Appel, J., Lamango, N.S., Houghten, R.A., Lindberg, I., Identification of inhibitors of prohormone convertases 1 and 2 using a peptide combinatorial library. J Biol Chem 273:41 (1998), 26589–26595.
131. Wei, S., Feng, Y., Che, F.Y., et al. Obesity and diabetes in transgenic mice expressing proSAAS. J Endocrinol 180:3 (2004), 357–368.
132. Morgan, D.J., Wei, S., Gomes, I., et al. The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation. J Neurochem 113:5 (2010), 1275–1284.
133. Gosmain, Y., Katz, L.S., Masson, M.H., Cheyssac, C., Poisson, C., Philippe, J., Pax6 is crucial for β-cell function, insulin biosynthesis, and glucose-induced insulin secretion. Mol Endocrinol 26 (2012), 696–709.
134. Wen, J.H., Chen, Y.Y., Song, S.J., et al. Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3). Diabetologia 52:3 (2009), 504–513.
135. Liu, T., Zhao, Y., Tang, N., et al. Pax6 directly down-regulates Pcsk1n expression thereby regulating PC1/3 dependent proinsulin processing. PloS One, 7, 2012, e46934.
136. Hoshino, A., Helwig, M., Razaei, S., Berridge, C., Eriksen, J., Lindberg, I., A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease. J Neurochem 128:3 (2014), 419–430.
137. Peinado, J.R., Sami, F., Rajpurohit, N., Lindberg, I., Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS. FEBS Lett 587:21 (2013), 3404–3411.